Zilretta: Clinical Trials

3 trials of Zilretta, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Terminated 1

Follow Zilretta: new trials by email Literature Review of Zilretta trials Research Report on Zilretta

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial Comparing Three Single Dose Injections for Knee Osteoarthritis
Zilretta, Synvisc-One 48 MG in 6 ML Prefilled Syringe, Monovisc 88 MG Per 4 ML Prefilled Syringe - Osteoarthritis, Knee
Phase 4TerminatedOhio State University62022-08-022026-09-17
Effect of ZILRETTA Versus CELESTONE on Quality of Life, Pain, Neuromuscular Function, and Physical Performance
Triamcinolone acetonide extended-release injectable suspension, Betamethasone sodium phosphate and betamethasone acetate Injectable Suspension - Osteoarthritis, Knee
Phase 4CompletedROC Foundation202020-11-302021-09-27
The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA
Zilretta - Knee Osteoarthritis
Phase 4CompletedUniversity of Kansas Medical Center702018-03-192022-05-05

Conditions studied

Osteoarthritis, Knee (3)

Sponsors

Ohio State University (1)  ·  ROC Foundation (1)  ·  University of Kansas Medical Center (1)

Countries

United States (3)

Top investigators

Michael Baria (1)  ·  Neil A Segal, MD (1)  ·  Sara C DePaoli (1)  ·  Timothy J Bray, MD (1)